A gel for wounds that won’t heal
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Jun-2026 21:16 ET (5-Jun-2026 01:16 GMT/UTC)
Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of reach for many, newly approved tablet forms are expected to significantly boost access and demand.
Researchers at The Ohio State University Wexner Medical Center and College of Medicine found that adding a stellate ganglion block (SGB) to cognitive processing therapy (CPT) helps military members and veterans feel better and recover from post-traumatic stress disorder (PTSD) symptoms more quickly.
Penn Nursing is proud to announce Diane Dodge, Executive Director of Tiba Foundation, as the recipient of the 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health. Dodge will be formally recognized on April 13, 2026, at the University of Pennsylvania’s Perry World House, where she will receive a $100,000 unrestricted grant to further her transformative work in women’s health care access and economic empowerment.
Women aged 63-99 with higher levels of grip strength and those who completed five unassisted sit-to-stand chair raises in the fastest amount of time had significantly lower death risk over an eight-year follow-up.
People with greater exposure to air pollution face a higher risk of developing Alzheimer’s disease, according to a new study by Yanling Deng of Emory University, U.S.A., and colleagues, published February 17th in the open-access journal PLOS Medicine.
UCLA researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with gene-editing machinery — a combination of large, complex components that non-viral carriers haven’t been able to handle before.
Using this delivery platform in a cell culture model of cystic fibrosis, researchers found that although only 3–4% of cells received the corrected gene, the treated cell populations restored 88–100% of normal function.
Replacing the entire faulty gene rather than correcting individual mutations may allow the therapy to work across all patients with cystic fibrosis.